Why do people participate in mass anti-malarial administration? Findings from a qualitative study in Nong District, Savannakhet Province, Lao PDR (Laos)

Malaria Journal

Volumn 17, Issue 1, 2018, Pages

  Adhikari, Bipin ^a,b,c   Phommasone, Koukeo ^d   Kommarasy, Palingnaphone ^d   Soundala, Xayaphone ^d   Souvanthong, Phonesavanh ^d   Pongvongsa, Tiengkham ^e   Henriques, Gisela ^a   Newton, Paul N ^b,d   White, Nicholas J ^a,b   Day, Nicholas P J ^a,b   Dondorp, Arjen M ^a,b   Von Seidlein, Lorenz ^a,b   Mayxay, Mayfong ^b,d,f   Cheah, Phaik Yeong ^a,b,g   Pell, Christopher ^h,i  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MAHOSOT HOSPITAL   (Laos)

^e Savannakhet Provincial Health Department   (Laos)

^f UNIVERSITY OF HEALTH SCIENCES   (Laos)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

ⁱ AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

Author keywords

Coverage; Factors; Laos; Malaria; Mass drug administration; Partnership; Qualitative; Trust; Volunteers

Indexed keywords

ANTIMALARIAL AGENT;

ADULT; AGED; ARTICLE; ATTITUDE; BLOOD EXAMINATION; COMMUNITY PARTICIPATION; CONTROLLED STUDY; DATA COLLECTION METHOD; DECREASED APPETITE; EDUCATIONAL STATUS; EPIGASTRIC PAIN; FATIGUE; FEMALE; HEADACHE; HEALTH CARE ACCESS; HUMAN; INFECTION RISK; KNOWLEDGE; LAOS; MALAISE; MALARIA; MALARIA CONTROL; MALE; OCCUPATION; PERCEPTION; PERSONAL HYGIENE; POVERTY; QUALITATIVE RESEARCH; SOCIAL PARTICIPATION; SOMNOLENCE; ADOLESCENT; CHILD; HEALTH CARE DELIVERY; INFANT; INTERVIEW; MASS DRUG ADMINISTRATION; MIDDLE AGED; PATIENT ATTITUDE; PRESCHOOL CHILD; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; INTERVIEWS AS TOPIC; LAOS; MALARIA; MALE; MASS DRUG ADMINISTRATION; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; YOUNG ADULT;

EID: 85040346698     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-017-2158-4     Document Type: Article

References (48)

1. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
2. Mbengue A, Bhattacharjee S, Pandharkar T, Liu H, Estiu G, Stahelin RV, et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature. 2015;520:683-7.
3. WHO. Accelerating malaria elimination in the Greater Mekong Subregion. Geneva: World Health Organization; 2014. http://www.who.int/malaria/areas/greater-mekong/overview/en/. Accessed 13 July 2017.
4. WHO. Strategy for Malaria Elimination in the Greater Mekong Subregion (2015-2030). Geneva: World Health Organization; 2015. http://iris.wpro.who.int/bitstream/handle/10665.1/10945/9789290617181-eng.pdf?sequence=1. Accessed 14 July 2017.
5. Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491-7.
6. von Seidlein L, Dondorp A. Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther. 2015;13:715-30.
7. Hanboonkunupakarn B, White NJ. The threat of artemisinin resistant malaria in Southeast Asia. Travel Med Infect Dis. 2016;14:548-50.
8. Lwin KM, Imwong M, Suangkanarat P, Jeeyapant A, Vihokhern B, Wongsaen K, et al. Elimination of Plasmodium falciparum in an area of multi-drug resistance. Malar J. 2015;14:319.
9. Kajeechiwa L, Thwin MM, Shee PW, Yee NL, Elvina E, Peapah P, et al. The acceptability of mass administrations of anti-malarial drugs as part of targeted malaria elimination in villages along the Thai-Myanmar border. Malar J. 2016;15:494.
10. Sahan K, Pell C, Smithuis F, Phyo AK, Maung SM, Indrasuta C, et al. Community engagement and the social context of targeted malaria treatment: a qualitative study in Kayin (Karen) State, Myanmar. Malar J. 2017;16:75.
11. Pell C, Tripura R, Nguon C, Cheah P, Davoeung C, Heng C, et al. Mass anti-malarial administration in western Cambodia: a qualitative study of factors affecting coverage. Malar J. 2017;16:206.
12. Tripura R, Peto TJ, Veugen CC, Nguon C, Davoeung C, James N, et al. Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia. Malar J. 2017;16:56.
13. Nguyen TN, Thu PN, Hung NT, Son DH, Tien NT, Van Dung N, et al. Community perceptions of targeted anti-malarial mass drug administrations in two provinces in Vietnam: a quantitative survey. Malar J. 2017;16:17.
14. Phommasone K, Adhikari B, Henriques G, Pongvongsa T, Phongmany P, von Seidlein L, et al. Asymptomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos). Malar J. 2016;15:296.
15. Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NP, et al. Community engagement and population coverage in mass anti-malarial administrations: a systematic literature review. Malar J. 2016;15:523.
16. Newby G, Hwang J, Koita K, Chen I, Greenwood B, von Seidlein L, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg. 2015;93:125-34.
17. Cheah PY, White NJ. Antimalarial mass drug administration: ethical considerations. Int Health. 2016;8:235-8.
18. Andriesse E, Phommalath A. Provincial poverty dynamics in Lao PDR: a case study of Savannakhet. J Curr Southeast Asian Aff. 2013;31:3-27.
19. International Monetary Fund. National Growth and Poverty Eradication Strategy. International Monetary Fund Publication Services; 2004. https://www.imf.org/external/pubs/ft/scr/2004/cr04393.pdf. Accessed Aug 2017.
20. Adhikari B, Pell C, Phommasone K, Soundala X, Kommarasy P, Pongvongsa T, et al. Elements of effective community engagement: lessons from a targeted malaria elimination study in Lao PDR (Laos). Glob Health Action. 2017;10:1366136.
21. Ovesen J. Indigenous peoples and development in Laos: ideologies and ironies. Recherche en sciences humaines sur l'Asie du Sud-Est. 2002;1(6):69-97.
22. Adhikari B, Phommasone K, Pongvongsa T, Kommarasy P, Soundala X, Henriques G, et al. Factors associated with population coverage of targeted malaria elimination (TME) in southern Savannakhet Province, Lao PDR. Malar J. 2017;16:424.
23. von Seidlein L. MORU TME brings water pumps to Laos villages; 2017. http://www.tropmedres.ac/moru-tme-brings-water-pumps-to-laos-villages. Accessed Aug 2017.
24. Adhikari B, Mishra SR, Raut S. Rebuilding earthquake struck Nepal through community engagement. Front Public Health. 2016;4:121.
25. Clinical and Translational Science Awards (CTSA). Principles of community engagement. NIH Publication No 11-7782. 2nd ed. Washington, DC: Clinical and Translational Science Awards (CTSA); 2011.
26. Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med. 2007;4:e273.
27. Pell C, Straus L, Andrew EV, Menaca A, Pool R. Social and cultural factors affecting uptake of interventions for malaria in pregnancy in Africa: a systematic review of the qualitative research. PLoS ONE. 2011;6:e22452.
28. Andrew EV, Pell C, Angwin A, Auwun A, Daniels J, Mueller I, et al. Knowledge, attitudes, and practices concerning malaria in pregnancy: results from a qualitative study in Madang, Papua New Guinea. PLoS ONE. 2015;10:e0119077.
29. Menaca A, Pell C, Manda-Taylor L, Chatio S, Afrah NA, Were F, et al. Local illness concepts and their relevance for the prevention and control of malaria during pregnancy in Ghana, Kenya and Malawi: findings from a comparative qualitative study. Malar J. 2013;12:257.
30. Peto TJ, Kloprogge SE, Tripura R, Nguon C, Sanann N, Yok S, et al. History of malaria treatment as a predictor of subsequent subclinical parasitaemia: a cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia. Malar J. 2016;15:240.
31. Tripura R, Peto TJ, Chalk J, Lee SJ, Sirithiranont P, Nguon C, et al. Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies. Malar J. 2016;15:181.
32. Chu CS, White NJ. Management of relapsing Plasmodium vivax malaria. Expert Rev Anti Infect Ther. 2016;14:885-900.
33. Haire BG, Ogundokun O. Ethics of ancillary care in clinical trials in low income countries: a Nigerian case study. Afr J Reprod Health. 2014;18:135-42.
34. Participants in Georgetown University Workshop on Ancillary-care obligations of medical researchers working in developing countries. The ancillary-care obligations of medical researchers working in developing countries. PLoS Med. 2008; 5:e90.
35. Belsky L, Richardson HS. Medical researchers' ancillary clinical care responsibilities. BMJ. 2004;328:1494-6.
36. Dickert N, DeRiemer K, Duffy PE, Garcia-Garcia L, Mutabingwa TK, Sina BJ, et al. Ancillary-care responsibilities in observational research: two cases, two issues. Lancet. 2007;369:874-7.
37. Pratt B, Zion D, Lwin KM, Cheah PY, Nosten F, Loff B. Ancillary care: from theory to practice in international clinical research. Public Health Ethics. 2013;6:154-69.
38. Molyneux S, Mulupi S, Mbaabu L, Marsh V. Benefits and payments for research participants: experiences and views from a research centre on the Kenyan coast. BMC Med Ethics. 2012;13:13.
39. Mfutso-Bengo J, Ndebele P, Jumbe V, Mkunthi M, Masiye F, Molyneux S, et al. Why do individuals agree to enrol in clinical trials? A qualitative study of health research participation in Blantyre, Malawi. Malawi Med J. 2008;20:37-41.
40. Dickert N, Wendler D. Ancillary care obligations of medical researchers. JAMA. 2009;302:424-8.
41. Geissler PW, Kelly A, Imoukhuede B, Pool R. He is now like a brother, I can even give him some blood'-relational ethics and material exchanges in a malaria vaccine 'trial community, The Gambia. Soc Sci Med. 2008;67:696-707.
42. De Martin S, von Seidlein L, Deen JL, Pinder M, Walraven G, Greenwood B. Community perceptions of a mass administration of an antimalarial drug combination in The Gambia. Trop Med Int Health. 2001;6:442-8.
43. Reeler AV. Injections: a fatal attraction? Soc Sci Med. 1990;31:1119-25.
44. Van Staa A, Hardon A. Injection practices in the developing world. Geneva: World Health Organization, WHO/DAP/964; 1996.
45. Li HK, Agweyu A, English M, Bejon P. An unsupported preference for intravenous antibiotics. PLoS Med. 2015;12:e1001825.
46. Kaneko A. A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop. 2010;114:177-83.
47. Trankell IB. On the road in Laos. An anthropological study of road construction and rural communities. Bangkok: White Lotus Press; 1999.
48. Hockings P. Encyclopedia of World Cultures, vol. V. East and Southeast Asia: GK Hall and Company; 1993.